Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA)

Rutella, S. ORCID: 0000-0003-1970-7375, Church, S.E., Vadakekolathu, J., Reeder, S., Sullivan, A.H., Warren, S., Baughman, J., Muth, J., Park, H., Uronis, H., Kang, Y., Ng, M.C.H., Enzinger, P., Lee, K.W., Huber, K., Wynter-Horton, A., Li, D., Bang, Y., Davidson-Moncada, J. and Catenacci, D.V., 2019. Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA). Annals of Oncology, 30 (Supp5), v38-v39. ISSN 0923-7534

Full text not available from this repository.
Item Type: Journal article
Publication Title: Annals of Oncology
Creators: Rutella, S., Church, S.E., Vadakekolathu, J., Reeder, S., Sullivan, A.H., Warren, S., Baughman, J., Muth, J., Park, H., Uronis, H., Kang, Y., Ng, M.C.H., Enzinger, P., Lee, K.W., Huber, K., Wynter-Horton, A., Li, D., Bang, Y., Davidson-Moncada, J. and Catenacci, D.V.
Publisher: Elsevier
Date: October 2019
Volume: 30
Number: Supp5
ISSN: 0923-7534
Identifiers:
NumberType
10.1093/annonc/mdz239.034DOI
S0923753419583545Publisher Item Identifier
1280141Other
Divisions: Schools > School of Science and Technology
Depositing User: Linda Sullivan
Date Added: 30 Jan 2020 09:53
Last Modified: 30 Jan 2020 09:53
URI: http://irep.ntu.ac.uk/id/eprint/39126

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year